sulfabenzamide has been researched along with sulfamethoxazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akgün, H; Berk, B; Karamelekoğlu, I; Kocagöz, T; Kurnaz, I; Oktem, S; Sarıbıyık, G | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Daneshfar, Z; Moghimi, H; Rostamizadeh, S | 1 |
3 other study(ies) available for sulfabenzamide and sulfamethoxazole
| Article | Year |
|---|---|
Synthesis and antimycobacterial activity of some phthalimide derivatives.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Drug Resistance, Multiple, Bacterial; Isoniazid; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phthalimides; Pyrazinamide | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Synthesis of sulfamethoxazole and sulfabenzamide metal complexes; evaluation of their antibacterial activity.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Staphylococcus aureus; Structure-Activity Relationship; Sulfamethoxazole; Sulfonamides | 2019 |